Study: Graphic smoking warnings work
A new study suggests that graphic or emotional antismoking advertisements are effective, according to an article on Newswise. Smokers who had seen these ads in
A new study suggests that graphic or emotional antismoking advertisements are effective, according to an article on Newswise. Smokers who had seen these ads in
A team of researchers at the University of California, Los Angeles (UCLA) School of Dentistry, has been awarded a $3.8 million research grant to develop
Dozens of British dentists inspected by health officials were not following infection control guidelines designed to prevent the spread of diseases such as HIV and
Positron emission tomography (PET) imaging with F-18 fluorothymidine (FLT) during treatment and early follow-up could predict therapeutic response and identify patients who need close follow-up
Researchers from Queen Mary, University of London have developed a new gene test that may detect precancerous cells in patients with oral lesions that appear
Imagine being able to treat a suspicious lesion on a patient’s tongue simply by applying a topical agent, waiting a few minutes, then exposing it
Periodontitis increases the risk of developing oral leukoplakia and mucosal lesions that are predisposed to become oral cancer, according to a study in Oral Oncology
Eating cruciferous vegetables can significantly reduce the risk of developing several cancers, including oral, esophageal, colorectal, breast, and kidney cancer, according to a study in
A research team in the department of oral medicine at Carolinas Medical Center in Charlotte, NC, has been awarded an $8 million National Institutes of
A media campaign in Detroit that utilized print, radio, billboards, and mailed surveys was effective in raising public awareness of oral cancer and influencing healthcare
The rates of people dying from cancer are predicted to decline by 17% in the U.K. by 2030, according to new statistics released by Cancer
BioAlliance Pharma has signed a licensing agreement with Vestiq Pharmaceuticals to commercialize its Oravig product in the U.S. for the treatment of oropharyngeal candidiasis in